ANDRIKOU, KALLIOPI
 Distribuzione geografica
Continente #
NA - Nord America 806
EU - Europa 415
AS - Asia 195
AF - Africa 50
SA - Sud America 38
Totale 1.504
Nazione #
US - Stati Uniti d'America 805
IT - Italia 84
SE - Svezia 80
SG - Singapore 79
UA - Ucraina 64
IE - Irlanda 49
RU - Federazione Russa 43
CI - Costa d'Avorio 39
CN - Cina 39
BR - Brasile 35
HK - Hong Kong 29
DE - Germania 28
TR - Turchia 25
DK - Danimarca 24
FI - Finlandia 20
KR - Corea 14
MA - Marocco 8
NL - Olanda 7
FR - Francia 6
IN - India 4
BD - Bangladesh 3
DZ - Algeria 3
GB - Regno Unito 3
AT - Austria 2
BE - Belgio 2
VN - Vietnam 2
AR - Argentina 1
CA - Canada 1
CO - Colombia 1
CZ - Repubblica Ceca 1
GR - Grecia 1
RS - Serbia 1
VE - Venezuela 1
Totale 1.504
Città #
Chandler 131
Jacksonville 64
Fairfield 53
Dublin 49
Ashburn 48
Boardman 46
Ann Arbor 40
Abidjan 39
New York 38
Wilmington 37
Seattle 33
Singapore 31
Hong Kong 29
Des Moines 28
Woodbridge 28
Cambridge 23
Turin 19
Houston 18
Lawrence 17
Princeton 17
Moscow 13
San Mateo 13
Centro 12
Beijing 8
Helsinki 8
San Diego 6
Rome 5
Belo Horizonte 4
Dallas 4
Milan 4
Pune 4
Washington 4
Wuxi 4
Los Angeles 3
Modena 3
Norwalk 3
São Paulo 3
Ancona 2
Brussels 2
Fortaleza 2
Guangzhou 2
Hanoi 2
Isola della Scala 2
London 2
Nanjing 2
Rio de Janeiro 2
Sassari 2
Vienna 2
Wuhan 2
Acarigua 1
Alcobaça 1
Amsterdam 1
Anápolis 1
Aparecida de Goiânia 1
Arcoverde 1
Ascoli Piceno 1
Betim 1
Bogotá 1
Bom Despacho 1
Cachoeira do Sul 1
Campinas 1
Caratinga 1
Carmo da Cachoeira 1
Caxias do Sul 1
Charata 1
Chicago 1
Dalian 1
Dhaka 1
Erechim 1
Falls Church 1
Fayetteville 1
Frankfurt (Oder) 1
Frankfurt am Main 1
Gramado 1
Guarulhos 1
Hounslow 1
Itapetininga 1
Itaúna 1
Izmir 1
Jinan 1
Jinhua 1
Kolomna 1
Linyi 1
Macerata 1
Mafra 1
Mogi Guaçu 1
Mogi das Cruzes 1
Mondolfo 1
Morrinhos 1
Murmansk 1
Newark 1
Olomouc 1
Pescara 1
Qingdao 1
Rio Grande 1
San Severino Marche 1
Santa Clara 1
Santa Maria a Monte 1
Santana de Parnaíba 1
Santo Amaro 1
Totale 964
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 139
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 137
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 124
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 113
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 113
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 97
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target 96
HER family receptor expression and prognosis in pancreatic cancer 90
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 87
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 79
Panitumumab for the treatment of metastatic colorectal cancer: A review 75
Trattamento del carcinoma del pancreas. Attualità e prospettive 74
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 74
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis 60
Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma 41
The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy 38
Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients 37
Brigatinib in the first-line treatment of ALK+ metastatic NSCLC: safety and efficacy 36
Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer 34
Totale 1.544
Categoria #
all - tutte 8.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 0 0 0 0 0 0 2 4 17
2020/2021258 17 21 29 3 17 15 20 16 24 54 32 10
2021/2022139 7 22 2 5 1 10 3 8 11 18 16 36
2022/2023392 24 53 28 29 26 66 1 16 94 6 38 11
2023/2024195 37 5 13 24 25 58 2 3 1 3 1 23
2024/2025302 74 30 8 10 27 26 37 11 58 21 0 0
Totale 1.544